The Wnt/β -catenin signaling pathway is over activated in SSc patients and expression of WIF1, a Wnt pathway antagonist, is decreased in SSc patients [41], likely through a reactive oxygen species-dependent transcriptional repression mechanism [42]. This evidence concerns the gene WIF1 and systemic sclerosis.